Tom Wilemon

February 13, 2020

Advocacy group’s gift boosts lung cancer research efforts

An advocacy group for patients with anaplastic lymphoma kinase positive lung cancer has awarded a $500,000 grant dedicated to overcoming treatment resistance to the cancer.

By Tom Wilemon
February 6, 2020

Stem cell recipient and donor meet in person for first time

Josh Ferris was sitting in a hunting blind on Nov. 15, 2018, the first day of deer season in Michigan and the one-year anniversary of his stem cell donation, when he received an email from Todd Adams of Nashville, the recipient of his life-saving gift.

By Tom Wilemon
February 5, 2020

Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report

Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.

By Tom Wilemon
February 5, 2020

Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.

By Tom Wilemon
January 16, 2020

Journey Home Project supports first CAR-T infusion at VA hospital

The Tennessee Valley Healthcare System performed its first CAR-T infusion recently at the Veterans Administration hospital in Nashville.

By Tom Wilemon
January 9, 2020

Park named interim Hematology and Oncology director

Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology.

By Tom Wilemon
January 9, 2020

Impact of weight gain from early to middle adulthood explored

An analysis of weight gain occurring from early to middle adulthood indicates that the added weight is associated with multiple health outcomes in later life.
By Tom Wilemon
December 12, 2019

Richmond receives legacy award from Society for Leukocyte Biology

Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.
By Tom Wilemon
December 5, 2019

Balko lands Mary Kay Foundation grant for breast cancer research

Vanderbilt-Ingram Cancer Center's Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.
By Tom Wilemon
November 20, 2019

Study finds breast cancer recurrence score has different implications for men

A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer
By Tom Wilemon
November 14, 2019

NCI ‘Moonshot’ grant to boost hereditary cancer identification

VUMC is leading an initiative to establish a streamlined process for collection of family health histories that could set the stage for a standardized system to make the information easily accessible.
By Tom Wilemon
November 7, 2019

VICC takes leading role in international cancer database project

Vanderbilt-Ingram Cancer Center is one of three institutions launching the first phase of a collaboration to advance precision oncology through the creation of a clinico-genomic dataset with an international reach.
By Tom Wilemon
1 … 21 22 23 24 25 … 39